Cerexa

Calixa Therapeutics

This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.

Qpex Biopharma

This biopharmaceutical company develops novel anti-infective therapies for patients with drug-resistant bacterial infections in inpatient and outpatient settings.

Arpida AG

This biopharmaceutical company develops novel antibiotics for hospital patients to treat severe infections caused by drug-resistant bacteria.

Arpida

This company develops antimicrobial drugs and broad-spectrum antibiotics to treat patients with severe bacterial infections requiring hospital treatment.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

SelectX Pharmaceuticals

This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.

Durata Therapeutics

The company develops and commercialises intravenous antibiotics to treat patients with acute bacterial skin and skin structure infections.

Novexel

Novexel develops novel antibacterial and antifungal agents for hospitals to treat drug-resistant infections and manage patient discharge from intravenous to oral therapy.